Skye Bioscience, Inc. (SKYE)

Last Year

26-Nov-23 -- 25-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

13

0

6

+1

0

+2

0

+3

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
01-Mar-24 6:42 PM View:	29-Feb-24 Grant 0	Arsenault Kaitlyn Melanie Chief Financial Officer		Skye Bioscience, Inc. - SKYE	13% 185.74K to 210.74K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 9:20 PM View:	18-Nov-24 Sale ($411.90K)	Dhillon Punit Chief Executive Officer Director		Skye Bioscience, Inc. - SKYE	14% 297.01K to 339.17K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 7:53 PM View:	29-Feb-24 Grant 0	Grayson Paul A. Director		Skye Bioscience, Inc. - SKYE	41% 246.25K to 346.25K	0	0	--	--	Show Txns Hide Txns

13-Sep-24 6:54 PM View:	13-Sep-24 Sale ($83.85K)	5am Partners Vii, LLC 10% Owner		Skye Bioscience, Inc. - SKYE	119% 4.52M to 9.91M	0	0	--	--	Show Txns Hide Txns

20-Nov-24 8:23 AM View:	18-Nov-24 Sale ($97.25K)	Diep Tuan Tu Chief Development Officer		Skye Bioscience, Inc. - SKYE	7% 76.83K to 82.26K	0	0	--	--	Show Txns Hide Txns

13-Sep-24 6:56 PM View:	13-Sep-24 Sale Duplicate ($83.85K)	Schwab Andrew J. Director 10% Owner		Skye Bioscience, Inc. - SKYE	119% 4.52M to 9.91M	0	0	--	--	Show Txns Hide Txns